Back to search

Article

The DMT and Psilocin Treatment Changes CD11b+ Activated Microglia Immunological Phenotype

2021-03-08

Abstract excerpt

Psychedelics are new, promising candidate molecules for clinical use in psychiatric disorders such as Treatment-Resistant Depression (TRD) and Post Traumatic Stress Disorder (PTSD). They were recently also proposed as molecules supporting neural tissue repair by anti-inflammatory properties. Here we reported that two classic psychedelics, DMT and psilocin, can influence microglial functions by reducing the level o...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
00fd2c0d-5cd4-562c-bcfd-2cb7d03a3454
DOI
10.1101/2021.03.07.434103
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The DMT and Psilocin Treatment Changes CD11b+ Activated Microglia Immunological PhenotypeDOI 10.1101/2021.03.07.434103
Select a neighboring publication to make it the new centre.